New Delhi: Government may extend direct financial assistance to designated covid-19 vaccine manufacturers for clinical trials in India.
Through the Department of Biotechnology, the Government is providing direct financial help to vaccine manufacturers for assisting in research and development activities, which presently includes pre-clinical trials only. “In future, may be extended for clinical trials also," said Rajesh Bhushan, Secretary, Ministry of Health and Family Welfare.Currently several indigenous vaccines are under various stages of clinical trials.
As far as cold chain infrastructure for vaccines is concerned, the National Committee for Vaccine Administration's sub-group has already mapped the available cold chain infrastructure.